As of November 6, 2026, Cibus, Inc. is a publicly traded company (Nasdaq: CBUS); its largest reported holder is Fidelity (FMR), with 15% on Schedule 13G/A of May 6, 2026. The largest insider holding is Rory B. Riggs, a director and 10% owner, with 14,961,421 shares, per Form 4 of February 2, 2026. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13G/A, May 6, 2026).
Is this your company?
About to sign with, pay or invest in Cibus, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Cibus, Inc. a real, registered company?
- Cibus, Inc. files with the SEC under CIK 1705843 (its SEC filings).
- Its shares are listed under the ticker CBUS on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in San Diego, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under CIBUS INC in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Craig Wichner, Chief Executive Officer (Form 8-K filed 2026-06-09). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Fidelity (FMR) (filed 2026-05-06).
Who are Cibus, Inc.'s owners and officers?
Cibus, Inc.: incorporated in Delaware; business address in San Diego, California; industry Agricultural Chemicals (Form D, 2026-06-09).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-05-06 | Fmr LLC | 15% |
| Schedule 13G/A, 2026-02-05 | Fmr LLC | 13.9% |
| Schedule 13G/A, 2025-08-14 | Armistice Capital, LLC | 4.99% |
Questions about who owns Cibus, Inc.
Who owns Cibus, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of Cibus, Inc.: Fmr LLC (15%, Schedule 13G/A, filed 2026-05-06).
When did Fmr LLC buy into Cibus, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Fmr LLC on this page is the Schedule 13G/A, filed 2026-02-05, reporting 13.9%; its latest, Schedule 13G/A filed 2026-05-06, reports 15%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 3 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Cibus, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cibus, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cibus, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-06-09 | Craig Wichner | Chief Executive Officer | appointed | |
| Form 8-K, 2026-06-09 | Craig Wichner | departed | ||
| Form 8-K, 2026-06-09 | Peter Beetham | Chief Executive Officer | departed | 2026-06-08 |
| Form 8-K, 2026-04-10 | Thomas Urban | Director | appointed |
Which insiders own Cibus, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director and 10% owner: 14,961,421 shares, 14,916,640 held directly and 44,781 indirectly (Form 4, 2026-02-02).
- , the chief executive: 894,309 shares (18.0% of shares outstanding) (Form 4, 2026-06-10).
- , a director: 763,904 shares (15.4% of shares outstanding) (Form 4, 2026-06-04).
- , the chief executive and president: 686,825 shares (13.8% of shares outstanding) (Form 4, 2026-04-28).
- , the chief scientific officer and executive vice president: 422,890 shares (8.5% of shares outstanding) (Form 4, 2026-04-28).
Shares outstanding: 4,973,687 as of 2023-04-28, from the company's latest SEC cover page.
How much has Cibus, Inc. raised?
No fundraising or offering filing from Cibus, Inc. is on file with us.
Keep reading
More on Cibus, Inc. and the records around it.
Cibus, Inc. elsewhere on the record
- Leadership changes Jun 2026
Companies that share a holder
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
- FMR LLC also filed stake reports on 761 other companies: ASPEN NEUROSCIENCE INC (Nov 2026), AVALO THERAPEUTICS INC (Nov 2026), BRAZE INC (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/cibus